Latest news about Fresita Proteins
Fresita Proteins
142.30
-7.46(-4.98%)
Company Performance:
View Company Insights1D-4.98%
1M0.00%
6M+68.44%
1Y0.00%
5Y+255.75%
More news about Fresita Proteins
16Jul 26
Sarda Proteins returns to profit in Q1FY26 with revenue of ₹1,847.40 lakh
Sarda Proteins Limited returned to profitability in Q1FY26 with a net profit of ₹165.97 lakh, reversing a net loss of ₹49.34 lakh in Q1FY25. Total revenue increased to ₹1,847.40 lakh, driven by higher revenue from operations and other income. The board also appointed Ms. Minal Surendra Jain as an Independent Director and approved the shifting of its registered office and establishment of a new corporate office.
07Jul 26
Sarda Proteins fixes July 23 cut-off date for EGM e-voting
Sarda Proteins Limited has fixed July 23, 2026, as the cut-off date for its EGM on July 30, 2026, to approve increasing authorised share capital to ₹100 crore and renaming the company to Sarda Enterprises Limited. The meeting will also consider appointing Shirish Dhirajlal Savaliya as Managing Director and Mr. Yagnik Satasiya as Non-Executive Chairperson. Remote e-voting is available from July 27 to July 29, 2026.
15Apr 26
Sarda Proteins Limited Submits Quarterly Compliance Certificate for Securities Dematerialization
Sarda Proteins Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) to BSE Limited on April 15, 2026, covering securities dematerialized during the quarter ended March 31, 2026. The certificate was received from registrar MUFG Intime India Private Limited, which confirmed proper processing of dematerialization requests within prescribed timelines and adherence to regulatory procedures for securities handling and record maintenance.
28Mar 26
Sarda Proteins Limited: Open Offer for 17,30,400 Equity Shares at ₹115 per Share by Onix Renewable Limited
Onix Renewable Limited has announced a mandatory open offer for 17,30,400 equity shares of Sarda Proteins Limited at ₹115 per share, representing 19.28% of emerging voting share capital. The offer, triggered by warrant conversion that increased the acquirer group's stake to 80.72%, involves total consideration of ₹19,89,96,000. The tendering period is scheduled from May 18-29, 2026, with Grow House Wealth Management as the offer manager.
19Mar 26
Sarda Proteins: Onix Renewable Files Regulatory Disclosure for 77.99% Stake Acquisition
Onix Renewable Limited has filed mandatory regulatory disclosure under SEBI Regulation 29(1) for acquiring 77.99% stake in Sarda Proteins Limited through warrant conversion. The substantial acquisition has triggered an open offer for the remaining 19.28% shareholding at Rs 115 per share, with the company's share capital expanding from Rs 1.73 crore to Rs 8.98 crore post-conversion.
18Mar 26
Sarda Proteins Board Approves Conversion of 72,50,000 Convertible Warrants to Equity
Sarda Proteins Limited officially completed the conversion of all 72,50,000 convertible warrants into equity shares following board approval on March 18, 2026. The conversion raised ₹62,53,12,500 from seven allottees, with Onix Renewable Limited contributing ₹60,37,50,000 for 70,00,000 warrants. The company's paid-up equity capital increased to ₹8,97,59,000 comprising 89,75,900 shares.
14Feb 26
Sarda Proteins Limited Announces Q3 FY26 Financial Results for Quarter Ended December 31, 2025
Sarda Proteins Limited announced unaudited financial results for the quarter and nine months ended December 31, 2025, following Board approval on February 14, 2026. The results were submitted to BSE under Regulation 33 compliance, accompanied by a clean review report from statutory auditors M/s. A H Mandaliya & Associates, confirming no material misstatements in the financial statements.
08Dec 25
Sarda Proteins Bolsters Leadership with Three New Directors
Sarda Proteins has appointed three new Additional Directors for five-year terms, subject to shareholder approval: Mr. Bipinkumar Babubhai Savalia, Mr. Gunvantray Jayantilal Zaladi, and Mr. Shivam Gunvantray Zaladi. The company's latest balance sheet shows a stable financial position with total assets increasing by 8.33% to ₹2.60 crore and current assets growing by 8.70% to ₹2.50 crore. Shareholders' capital and total equity remain unchanged at ₹2.40 crore, while current liabilities increased to ₹0.20 crore from zero in the previous year.
29Nov 25
Sarda Proteins Reports Mixed Q2 Results: Revenue Surge Amidst Half-Year Loss
Sarda Proteins Limited reported mixed financial results for Q2 and H1 FY2026. Q2 saw revenue of Rs 430.38 lakhs and net profit of Rs 40.46 lakhs. However, H1 results showed revenue of Rs 1,525.84 lakhs with a net loss of Rs 8.88 lakhs. The company's total assets grew remarkably by 3,190% to Rs 8,712.54 lakhs as of September 30, 2025, compared to Rs 264.80 lakhs on March 31, 2025, driven by higher trade receivables and increased advances.
22Jul 25
Sarda Proteins Limited Board to Consider Name Change to Onix Power and Key Appointments
Sarda Proteins Limited has scheduled a Board of Directors meeting for July 26, 2025, to discuss significant proposals including changing the company name to Onix Power Limited, appointing Ms. Rinkal Malviya as a Woman Director, relocating the registered office, and addressing governance matters such as approving an EGM notice and appointing a scrutinizer for voting. The meeting will be held via video conferencing at 11:00 A.M.
Industry Peers
Marico
Patanjali Foods
AWL Agri Business
Gokul Agro Resources
CIAN Agro Industries & Infrastructure
Sundrop Brands
Shri Venkatesh Refineries
BCL Industries
Gokul Refoils & Solvent
Evexia Lifecar
781.35
(-0.59%)
355.15
(-2.16%)
175.43
(-1.27%)
210.10
(-1.35%)
1,015.75
(-4.91%)
753.15
(+1.07%)
681.50
(+4.53%)
31.24
(-1.73%)
38.66
(-1.93%)
2.01
(+4.69%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
